DSGN Operating Cash Flow (Statement)
Design Therapeutics Inc · Operating Cash Flow (Statement)
DSGN Operating Cash Flow (Statement)
Latest reported-$55.08Mperiod ending
DSGN TTM Cash from Operations (-$8.67M → -$55.08M)
TTM operating cash flow (statement)
High-resolution chart · PNG
DSGN operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -55,083,000 | |
| -54,000,000 | |
| -54,358,000 | |
| -52,252,000 | |
| -50,636,000 | |
| -47,455,000 | |
| -43,105,000 | |
| -46,043,000 | |
| -51,031,000 | |
| -53,575,000 | |
| -58,560,000 | |
| -60,853,000 | |
| -60,218,000 | |
| -56,914,000 | |
| -51,317,000 | |
| -45,453,000 | |
| -39,718,000 | |
| -37,507,000 | |
| -29,377,000 | |
| -22,994,000 | |
| -16,689,000 | |
| -9,707,000 | |
| -8,669,000 |